Comment
doi: 10.1111/apt.12931.
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply
Affiliations
- PMID: 25185739
- DOI: 10.1111/apt.12931
Item in Clipboard
Comment
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply
Aliment Pharmacol Ther.
2014 Oct.
No abstract available
Comment on
-
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.Aliment Pharmacol Ther. 2014 May;39(9):984-91. doi: 10.1111/apt.12693. Epub 2014 Mar 11. Aliment Pharmacol Ther. 2014. PMID: 24617286
-
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus.Aliment Pharmacol Ther. 2014 Oct;40(7):859-60. doi: 10.1111/apt.12892. Aliment Pharmacol Ther. 2014. PMID: 25185738 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical